Solid lipid nanoparticles: Formulation factors affecting cell transfection capacity

International Journal of Pharmaceutics

Volumn 339, Issue 1-2, 2007, Pages 261-268

  del Pozo Rodriguez A ^a   Delgado, D ^a   Solinis M A ^a   Gascon A R ^a   Pedraz, J L ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

"In vitro" transfection; Gene therapy; Non viral vectors; Solid lipid nanoparticles

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; DNA; GLYCEROL PALMITOSTEARATE; LIPID; NANOPARTICLE; POLYSORBATE 80; SURFACTANT;

ARTICLE; CELL STRAIN HEK293; CELL VIABILITY; COMPLEX FORMATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; POLYMERIZATION; PRIORITY JOURNAL; SOLID; SURFACE PROPERTY;

CELL SURVIVAL; CELLS, CULTURED; CHEMISTRY, PHARMACEUTICAL; DEOXYRIBONUCLEASE I; DNA; DRUG CARRIERS; FATTY ACIDS, MONOUNSATURATED; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; NANOPARTICLES; POLYSORBATES; QUATERNARY AMMONIUM COMPOUNDS; TRANSFECTION;

EID: 34250862793     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.03.015     Document Type: Article

References (24)

1. Elouahabi A., Thiry M., Pector V., Ruysschaert J.M., and Vandenbranden M. Calorimetry of cationic liposome-DNA complex and intracellular visualization of the complexes. Meth. Enzymol. 373 (2003) 312-332
2. Elouahabi A., and Ruysschaert J.M. Formation and intracellular trafficking of lipoplexes and polyplexes. Mol. Ther. 11 (2005) 336-347
3. Faneca H., Simoes S., and de Lima M.C.P. Evaluation of lipid-based reagents to mediate intracellular gene delivery. Biochim. Biophys. Acta 1567 (2002) 23-33
4. Ferrari M.E., Nguyen C.M., Zelphati O., Tsai Y.L., and Felgner P.L. Analytical methods for the characterization of cationic lipid nucleic acid complexes. Hum. Gene Ther. 9 (1998) 341-351
5. Freitas C., and Müller R.H. Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase. Eur. J. Pharm. Biopharm. 47 (1999) 125-132
6. Han S.O., Mahato R.I., Sung Y.K., and Kim S.W. Development of biomaterials for gene therapy. Mol. Ther. 2 (2000) 302-317
7. Harvie P., Wong Frances M.P., and Bally Marcel B. Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid-DNA particles. J. Pharm. Sci. 89 (2006) 652-663
8. Hyndman L., Lemoine J.L., Huang L., Porteous D.J., Boyd A.C., and Nan X.S. HIV-1 Tat protein transduction domain peptide facilitates gene transfer in combination with cationic liposomes. J. Control. Rel. 99 (2004) 435-444
9. Liu F., Yang J., Huang L., and Liu D. Effect of non-ionic surfactants on the formation of DNA/emulsion complexes and emulsion-mediated gene transfer. Pharm. Res. 13 (1996) 1642-1646
10. Liu F., Yang J., Huang L., and Liu D. New cationic lipid formulations for gene transfer. Pharm. Res. 13 (1996) 1856-1860
11. Mahato R.I., Kawabata K., Nomura T., Takakura Y., and Hashida M. Physicochemical and pharmacokinetic characteristics of plasmid DNA cationic liposome complexes. J. Pharm. Sci. 84 (1995) 1267-1271
12. Mehnert W., and Mader K. Solid lipid nanoparticles-production, characterization and applications. Adv. Drug Deliv. Rev. 47 (2001) 165-196
13. Meyer O., Kirpotin D., Hong K.L., Sternberg B., Park J.W., Woodle M.C., and Papahadjopoulos D. Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides. J. Biol. Chem. 273 (1998) 15621-15627
14. Middaugh C.R., Evans R.K., Montgomery D.L., and Casimiro D.R. Analysis of plasmid DNA from a pharmaceutical perspective. J. Pharm. Sci. 87 (1998) 130-146
15. Olbrich C., Bakowsky U., Lehr C.M., Muller R.H., and Kneuer C. Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA. J. Control. Rel. 77 (2001) 345-355
16. Pedersen N., Hansen S., Heydenreich A.V., Kristensen H.G., and Poulsen H.S. Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands. Eur. J. Pharm. Biopharm. 62 (2006) 155-162
17. Rejman J., Bragonzi A., and Conese M. Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes. Mol. Ther. 12 (2005) 468-474
18. Remaut K., Sanders N.N., Fayazpour F., Demeester J., and De Smedt S.C. Influence of plasmid DNA topology on the transfection properties of dotap/dope lipoplexes. J. Control. Rel. 115 (2006) 335-343
19. Rudolph C., Schillinger U., Ortiz A., Tabatt K., Plank C., Müller R., and Rosenecker J. Application of novel solid lipid nanoparticles (SLN)-gene vector formulations based on a dimeric HIV-1 Tat-peptide in vitro and in vivo. Pharm. Res. 21 (2004) 1662-1669
20. Sakurai F., Inoue R., Nishino Y., Okuda A., Matsumoto O., Taga T., Yamashita F., Takakura Y., and Hashida M. Effect of DNA/liposome mixing ratio on the physicochemical characteristics, cellular uptake and intracellular trafficking of plasmid DNA/cationic liposome complexes and subsequent gene expression. J. Control. Rel. 66 (2000) 255-269
21. Sanders N.N., De Smedt S.C., and Demeester J. In: McGrath B.M., and Walsh G. (Eds). Therapeutic Enzymes (2006), Taylor & Francis Group, Boca Raton 97-116
22. Tabatt K., Kneuer C., Sameti M., Olbrich C., Muller R.H., Lehr C.M., and Bakowsky U. Transfection with different colloidal systems: comparison of solid lipid nanoparticles and liposomes. J. Control. Rel. 97 (2004) 321-332
23. Tabatt K., Sameti M., Olbrich C., Muller R.H., and Lehr C.M. Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer. Eur. J. Pharm. Biopharm. 57 (2004) 155-162
24. Tokunaga M., Hazemoto N., and Yotsuyanagi T. Effect of oligopeptides on gene expression: comparison of DNA/peptide and DNA/peptide/liposome complexes. Int. J. Pharm. 269 (2004) 71-80